- ETF Trends•3 days ago
The BioShares Biotechnology Products Fund (NasdaqGM: BBP) has capitalized on a string of acquisitions and outperformed other biotechnology- and pharmaceuticals-related exchange traded funds. BBP, which ...
- Capital Cube•4 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Progenics Pharmaceuticals, Inc.Here are 5 ETF’s with the largest exposure to PGNX-US. Comparing the performance and risk of Progenics Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Progenics Pharmaceuticals, Inc. : July 21, 2016 appeared first on CapitalCube.
Progenics Pharmaceuticals, Inc.NasdaqGS
After hours: 6.010.00 (0.00%) as of 5:42 PM EDT
|Bid||6.00 x 10000|
|Ask||6.48 x 100|
|52wk Range||3.61 - 11.15|
|Day's Range||5.96 - 6.25|
|Avg Vol (3m)||1,322,303|
As of 4:00 PM EDT. Market closed.